Exclusive: FTC Expected To Make Mylan-Upjohn Announcement Today
FTC Approval A Major Hurdle To Deal Completion
Almost 500 days after the transaction was first announced, Viatris, the proposed combination of Mylan and Pfizer’s Upjohn, is set to receive word from the US Federal Trade Commission, representing the last major obstacle to getting the deal over the line.
